Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.52 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.49 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.47 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.47 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1576849 | 0.93 | MCL1 (0.69) | MCL1PTPN11KAT8 | |
| SCHEMBL29623897 | 0.93 | MCL1 (0.69) | MCL1PTPN11KAT8 | |
| SCHEMBL9285957 | 0.90 | MCL1 (0.66) | MCL1PTPN11KAT8 | |
| SCHEMBL29623817 | 0.89 | PTPN11 (0.67) | MCL1PTPN11KAT8 | |
| SCHEMBL223621 | 0.89 | PTPN11 (0.67) | MCL1PTPN11KAT8 | |
| SCHEMBL4653931 | 0.89 | PTPN11 (0.67) | MCL1PTPN11KAT8 | |
| SCHEMBL29623919 | 0.89 | PTPN11 (0.67) | MCL1PTPN11KAT8 | |
| SCHEMBL11694352 | 0.89 | PTPN11 (0.67) | MCL1PTPN11KAT8 | |
| SCHEMBL1576902 | 0.89 | PTPN11 (0.67) | MCL1PTPN11KAT8 | |
| SCHEMBL538994 | 0.87 | KMT2A (0.55) | MCL1KMT2AHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0987011-B1 | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | OREAL (FR) | 2002-07-17 | — | — | EP | claimed |
| US-6281203-B1 | ESTER OF A FATTY ACID AND GLUCOSE AND/OR ALKYLGLUCOSE, AND AN OXYETHYLENATED ETHER OF A FATTY ACID ESTER OF GLUCOSE AND/OR ALKYLGLUCOSE. | L'OREAL (FR) | 2001-08-28 | — | — | US | claimed |
| EP-3389595-B1 | COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC ACID HAVING TWO OR MORE ACID DISSOCIATION CONSTANTS | OREAL (FR) | 2025-11-05 | — | — | EP | disclosed |
| EP-3638192-B1 | COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC ACID OR BASE HAVING TWO OR MORE DISSOCIATION CONSTANTS | OREAL (FR) | 2025-04-02 | — | — | EP | disclosed |
| EP-3638201-B1 | COMBINATION OF POLYION COMPLEX PARTICLE AND NON-POLYMERIC BASE HAVING TWO OR MORE DISSOCIATION CONSTANTS | OREAL (FR) | 2025-02-26 | — | — | EP | disclosed |
| WO-2024219512-A1 | COMPOSITION COMPRISING CHITOSAN AND SALICYLIC ACID OR DERIVATIVES THEREOF | L'OREAL (FR) | 2024-10-24 | — | — | WO | disclosed |
| WO-2024214568-A1 | WATER-BASED COSMETIC | 株式会社 資生堂 | 2024-10-17 | — | — | WO | disclosed |
| US-12029303-B2 | Method for preparation of a cosmetic kit | SHISEIDO COMPANY, LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| CN-110446488-B | Two-dose cosmetic | 株式会社资生堂 | 2024-07-02 | — | — | CN | disclosed |
| WO-2024135300-A1 | COSMETIC COMPOSITION, COSMETIC COMPOSITION FOR SUPPRESSING DISCOLORATION, AND DISCOLORATION SUPPRESSANT | 株式会社資生堂 | 2024-06-27 | — | — | WO | disclosed |
| US-11975093-B2 | Composition comprising oil and polyion complex including cellulose-based cationic polymer with at least one fatty chain | L'OREAL (FR) | 2024-05-07 | — | — | US | disclosed |
| US-20030036558-A1 | Substituted phenoxyacetic acids | THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. | 2003-02-20 | — | — | US | disclosed |
| CN-1364153-A | Substituted phenoxyacetic acids | INST PHARMACEUTICAL DISCOVERY (US) | 2002-08-14 | — | — | CN | disclosed |
| US-6420426-B1 | USED TO TREAT COMPLICATIONS FROM DIABETES MELLITUS | THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC | 2002-07-16 | — | — | US | disclosed |
| EP-1198451-A2 | SUBSTITUTED PHENOXYACETIC ACIDS | The Institutes for Pharmaceutical Discovery, LLC (US) | 2002-04-24 | — | — | EP | disclosed |
| US-6281203-B1 | ESTER OF A FATTY ACID AND GLUCOSE AND/OR ALKYLGLUCOSE, AND AN OXYETHYLENATED ETHER OF A FATTY ACID ESTER OF GLUCOSE AND/OR ALKYLGLUCOSE. | L'OREAL (FR) | 2001-08-28 | — | — | US | disclosed |
| WO-2001000566-A2 | SUBSTITUTED PHENOXYACETIC ACIDS | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) | 2001-01-04 | — | — | WO | disclosed |
| EP-0570230-B1 | External preparation for skin | SHISEIDO CO LTD (JP) | 1998-09-30 | — | — | EP | disclosed |
| US-5580549-A | BLEACHING; 2-HYDROXYBENZOIC ACID COMPOUND | SHISEIDO CO., LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| EP-0570230-A1 | External preparation for skin | SHISEIDO COMPANY LIMITED (JP) | 1993-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975093-B2 | Composition comprising oil and polyion complex including cellulose-based cationic polymer with at least one fatty chain | PRKCA, PRKCH, CUTA | MCL1 4066/4885KMT2A 1749/4885HTT 3784/4885 |
| US-20030036558-A1 | Substituted phenoxyacetic acids | SLC5A2, GPR119, SLC5A1 | MCL1 4465/4885KMT2A 2151/4885HTT 2418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.